Search - tctmd.com

Displaying 221 - 240 of 1248

Sort: Relevancy | Date

News Conference News AHA 2023

‘Proof-of-Concept’ AI-ECG May Improve STEMI Care: ARISE

Yael L. Maxwell

November 17, 2023

AZALEA-TIMI 71: Abelacimab Slashes Bleeds vs Rivaroxaban in AF, but Stroke Impact Unclear

News Conference News AHA 2023

NOW PUBLISHED - AZALEA-TIMI 71: Bleeds Plunge With Abelacimab vs Rivaroxaban in AF, but Stroke Impact Unclear

L.A. McKeown

November 12, 2023

News Conference News AHA 2023

Full SELECT Results Affirm CV Risk Reduction With Semaglutide in Nondiabetics

Todd Neale

November 11, 2023

Dropping Aspirin Cuts Strokes, Bleeds, Hospital Stays in LVAD Patients: ARIES-HCM3

News Conference News AHA 2023

Dropping Aspirin Cuts Strokes, Bleeds, Hospital Stays in LVAD Patients: ARIES-HM3

Shelley Wood

November 11, 2023

News Conference News AHA 2023

Placebo-Controlled ORBITA-2 Shows PCI Eases Symptoms in Stable Angina

Michael O'Riordan

November 11, 2023

News Conference News AHA 2023

DAPA-MI: Cardiometabolic Endpoints ‘Win’ With Dapagliflozin After Acute MI

Shelley Wood

November 11, 2023

News Daily News

FDA Grants Tirzepatide a New Indication for Obesity Management

L.A. McKeown

November 08, 2023

News Opinion Editor's Corner AHA 2023

What’s Going to Be Hot at AHA 2023

Shelley Wood

November 07, 2023

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for October 2023

Shelley Wood

November 01, 2023

News Conference News TCT 2023

‘Big Step Forward’ for Transcatheter Tricuspid Valve Replacement: TRISCEND II

Michael O'Riordan

October 26, 2023

News Daily News

US Cardiologists’ Pay, Productivity Held Steady in 2022: MedAxiom Survey

Caitlin E. Cox

October 16, 2023

News Daily News

Stark Inequities Plague AVR Rates for Women, Minorities in England

L.A. McKeown

October 04, 2023

News Daily News

Large Study Bolsters Feasibility of Heart Donation After Circulatory Death

Yael L. Maxwell

October 04, 2023

News Daily News

TCTMD’s Top 10 Most Popular Stories for September 2023

Shelley Wood

October 03, 2023

News Daily News

PET-Guided Strategy Lowers Risk, Boosts Outcomes in Stable CAD: CENTURY

Michael O'Riordan

September 29, 2023

News Daily News

Etripamil Continues to Show Promise in Paroxysmal SVT: NODE-302

Caitlin E. Cox

September 27, 2023

News Daily News

CRT With His-Purkinje Conduction System Pacing Succeeds in Pilot RCT

Todd Neale

September 20, 2023

News Daily News

‘Shocking’ Sexual Misconduct in Surgery Survey Prompts New Calls for Change

Shelley Wood

September 19, 2023

News Daily News

‘Astonishing’ Rates of CVD Linked to Lead Exposure

Caitlin E. Cox

September 13, 2023

News Daily News

Lorundrostat, an Aldosterone Synthase Inhibitor, Passes Phase II Hurdle

Todd Neale

September 12, 2023

Advertisement

‘Proof-of-Concept’ AI-ECG May Improve STEMI Care: ARISE

NOW PUBLISHED - AZALEA-TIMI 71: Bleeds Plunge With Abelacimab vs Rivaroxaban in AF, but Stroke Impact Unclear

Full SELECT Results Affirm CV Risk Reduction With Semaglutide in Nondiabetics

Dropping Aspirin Cuts Strokes, Bleeds, Hospital Stays in LVAD Patients: ARIES-HM3

Placebo-Controlled ORBITA-2 Shows PCI Eases Symptoms in Stable Angina

DAPA-MI: Cardiometabolic Endpoints ‘Win’ With Dapagliflozin After Acute MI

FDA Grants Tirzepatide a New Indication for Obesity Management

What’s Going to Be Hot at AHA 2023

TCTMD’s Top 10 Most Popular Stories for October 2023

‘Big Step Forward’ for Transcatheter Tricuspid Valve Replacement: TRISCEND II

US Cardiologists’ Pay, Productivity Held Steady in 2022: MedAxiom Survey

Stark Inequities Plague AVR Rates for Women, Minorities in England

Large Study Bolsters Feasibility of Heart Donation After Circulatory Death

TCTMD’s Top 10 Most Popular Stories for September 2023

PET-Guided Strategy Lowers Risk, Boosts Outcomes in Stable CAD: CENTURY

Etripamil Continues to Show Promise in Paroxysmal SVT: NODE-302

CRT With His-Purkinje Conduction System Pacing Succeeds in Pilot RCT

‘Shocking’ Sexual Misconduct in Surgery Survey Prompts New Calls for Change

‘Astonishing’ Rates of CVD Linked to Lead Exposure

Lorundrostat, an Aldosterone Synthase Inhibitor, Passes Phase II Hurdle

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content